StrategyHHS Drug Pricing Advisor to Depart
John O'Brien had replaced Dan Best after his predecessor's death in November 2018.
Are Trump's Top Medicaid Regulators Ignoring Major Problems?
The CEO of Centene, a company now entangled in a broader federal inquiry, met with Sen. Bob Casey to allay...
FinanceCMS Unveils Sweeping Proposed Mandates on Hospital Pricing Transparency
Under the proposed rule hospitals would have to make their 'real, negotiated prices known to patients.'
Strategy7 Strategies for ACO Success
The report comes amid projections that Medicare spending will exceed $1.5 trillion by 2028, which is more than double the...
HHS Chief: Medicare Payment Should be 'Patient-Centered'
New primary care payment models are a good start, says Azar.
StrategyAzar and Verma: Competition, Value-Based Models Needed to Fix Our Cost Problem
Both the HHS secretary and CMS administrator cited the competition among Medicare Advantage plans as a model of success.
HHS OIG Offers 25 Ways to Reduce Healthcare Waste and Fraud
OIG says these recommendations 'would most positively affect HHS programs in terms of cost savings, program effectiveness and efficiency, and...
FinanceMissouri Firm With Silicon Valley Ties Faces Medicare Billing Scrutiny
A recent HHS audit and a whistleblower lawsuit, have put Essence scrutiny. Medicare is conducting a separate audit.
StrategyHigh CEO Turnover Cited in Hospital's Temporary ER Closure
An HHS OIG review listed frequent leadership changes and poor transition planning among the major causes of the Indian Health...
FinanceMedicare Advantage Overbills Taxpayers By Billions A Year As Feds Struggle To Stop It
Officials have known for years that some Medicare Advantage plans overcharge for treating serious medical conditions they cannot prove their...
StrategyR.I.P. Rebate Rule: Centerpiece Plucked From Trump's Drug Pricing Blueprint
The administration abandoned its proposal to reduce prescription drug costs by curbing the rebates negotiated between PBMs and drug makers.
FinancePBMs Applaud Trump Administration Withdrawing Rebate Rule, Stocks Soar
Thursday's announcement was warmly received by pharmacy benefit managers.